Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation

14d ago

CYTO

PremiumPress Releases

Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal

21d ago

CYTO

PremiumCompany Announcements

Altamira Therapeutics Announces 2024 Annual Meeting

29d ago

CYTO

PremiumPress Releases

Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024

1M ago

CYTO

PremiumPress Releases

Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines

2M ago

CYTO

PremiumPress Releases

Altamira Therapeutics’ Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal

3M ago

CYTO

PremiumPress Releases

Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

4M ago

CYTO

More CYTO News >

CYTO News on the Web

2024-05-01

Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation

Yahoo Finance

Neutral

2024-04-24

Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal

Yahoo Finance

Neutral

2024-04-17

Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on April 18, 2024

Yahoo Finance

Neutral

2024-04-16

Altamira Therapeutics Announces 2024 Annual Meeting

TipRanks News

Neutral

2024-04-10

Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results

Yahoo Finance

Neutral

2024-04-04

Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024

Yahoo Finance

Neutral

2024-03-28

Is Altamira Therapeutics Ltd (CYTO) Stock a Smart Value Thursday?

Investors Observer

Neutral

2024-03-27

Should You Accumulate Altamira Therapeutics Ltd (CYTO) Stock Wednesday Morning?

Investors Observer

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CYTO’s Media Buzz Sentiment?

Currently, no data Available

What is CYTO’s weekly average amount of articles?

Currently, no data Available

What is CYTO’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

MTDMettler-Toledo

SYRESpyre Therapeutics

CRNXCrinetics Pharmaceuticals

HAEHaemonetics

LEGNLegend Biotech

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing